PDCD1 and cancer: In recent decades, immunotherapy has gradually emerged as a promising area of cancer treatment, in which cytotoxic T lymphocyte antigen-4 (CTLA-4) and programmed cell death protein-1 (PD-1) is the most effective T cell immune checkpoint molecule and plays a negative immunoregulatory role (8).